Search

Your search keyword '"Haferkamp A"' showing total 196 results

Search Constraints

Start Over You searched for: Author "Haferkamp A" Remove constraint Author: "Haferkamp A" Database ScienceDirect Remove constraint Database: ScienceDirect
196 results on '"Haferkamp A"'

Search Results

4. Biomarker screen for efficacy of oncolytic virotherapy in patient-derived pancreatic cancer cultures

6. Effects of an immunosuppressive therapy on the efficacy of immune checkpoint inhibition in metastatic melanoma – An analysis of the prospective skin cancer registry ADOREG

9. Adjuvant immunotherapy with nivolumab versus observation in completely resected Merkel cell carcinoma (ADMEC-O): disease-free survival results from a randomised, open-label, phase 2 trial

11. Immune checkpoint inhibition in patients with NRAS mutated and NRAS wild type melanoma: a multicenter Dermatologic Cooperative Oncology Group study on 637 patients from the prospective skin cancer registry ADOREG

14. Adjuvant nivolumab plus ipilimumab or nivolumab alone versus placebo in patients with resected stage IV melanoma with no evidence of disease (IMMUNED): final results of a randomised, double-blind, phase 2 trial

15. Model soups improve performance of dermoscopic skin cancer classifiers

17. Deep learning approach to predict sentinel lymph node status directly from routine histology of primary melanoma tumours

18. Characterization of PD-1 and PD-L1 Expression in Papillary Renal Cell Carcinoma: Results of a Large Multicenter Study

23. Association of an organ transplant-based approach with a dramatic reduction in postoperative complications following radical nephrectomy and tumor thrombectomy in renal cell carcinoma

25. Patients’ and dermatologists’ preferences in artificial intelligence–driven skin cancer diagnostics: A prospective multicentric survey study

28. Using multiple real-world dermoscopic photographs of one lesion improves melanoma classification via deep learning

30. Effect of Hospital and Surgeon Case Volume on Perioperative Quality of Care and Short-term Outcomes After Radical Cystectomy for Muscle-invasive Bladder Cancer: Results From a European Tertiary Care Center Cohort

32. Prognostic factors and outcomes in metastatic uveal melanoma treated with programmed cell death-1 or combined PD-1/cytotoxic T-lymphocyte antigen-4 inhibition

33. The Use of Neoadjuvant Chemotherapy in Patients With Urothelial Carcinoma of the Bladder: Current Practice Among Clinicians

34. 25P Change in splenic volume as a surrogate marker for immunotherapy response in patients with advanced urothelial and renal cell carcinoma: Evaluation of a novel approach of fully automated artificial intelligence based splenic segmentation

35. LDHA-Associated Lactic Acid Production Blunts Tumor Immunosurveillance by T and NK Cells

40. Impact of Synchronous Metastasis Distribution on Cancer Specific Survival in Renal Cell Carcinoma after Radical Nephrectomy with Tumor Thrombectomy

41. Impact of Histologic Subtype on Cancer-specific Survival in Patients with Renal Cell Carcinoma and Tumor Thrombus

47. Gender-specific differences in cancer-specific survival after radical cystectomy for patients with urothelial carcinoma of the urinary bladder in pathologic tumor stage T4a

48. Prediction of outcome in patients with urothelial carcinoma of the bladder following radical cystectomy using artificial neural networks

Catalog

Books, media, physical & digital resources